[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1641352T3 - Sammensætninger til forbedret oxidativ status hos katte - Google Patents

Sammensætninger til forbedret oxidativ status hos katte

Info

Publication number
DK1641352T3
DK1641352T3 DK04756796.1T DK04756796T DK1641352T3 DK 1641352 T3 DK1641352 T3 DK 1641352T3 DK 04756796 T DK04756796 T DK 04756796T DK 1641352 T3 DK1641352 T3 DK 1641352T3
Authority
DK
Denmark
Prior art keywords
compositions
cats
improved oxidative
oxidative status
levels
Prior art date
Application number
DK04756796.1T
Other languages
English (en)
Inventor
Kim Gene Friesen
Dennis Edward Jewell
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34079100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1641352(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of DK1641352T3 publication Critical patent/DK1641352T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Fodder In General (AREA)
DK04756796.1T 2003-07-07 2004-07-02 Sammensætninger til forbedret oxidativ status hos katte DK1641352T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48519403P 2003-07-07 2003-07-07
PCT/US2004/021929 WO2005006878A1 (en) 2003-07-07 2004-07-02 Compositions for improved oxidative status in companion animals

Publications (1)

Publication Number Publication Date
DK1641352T3 true DK1641352T3 (da) 2010-12-06

Family

ID=34079100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04756796.1T DK1641352T3 (da) 2003-07-07 2004-07-02 Sammensætninger til forbedret oxidativ status hos katte

Country Status (15)

Country Link
US (3) US20050014698A1 (da)
EP (1) EP1641352B2 (da)
JP (3) JP2007525201A (da)
CN (1) CN101052312B (da)
AT (1) ATE480152T1 (da)
AU (1) AU2004257683B2 (da)
BR (1) BRPI0412332A (da)
CA (1) CA2529377C (da)
DE (1) DE602004029039D1 (da)
DK (1) DK1641352T3 (da)
ES (1) ES2349927T3 (da)
MX (1) MXPA05013251A (da)
RU (1) RU2358440C2 (da)
WO (1) WO2005006878A1 (da)
ZA (1) ZA200600175B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004029039D1 (de) * 2003-07-07 2010-10-21 Hills Pet Nutrition Inc Zusammensetzungen für einen verbesserten oxidationsstatus bei katzen
FR2884421B1 (fr) * 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
ES2279719B1 (es) * 2006-01-26 2008-07-16 Timac Agro España, S.A. Nuevo activador metabolico y nutricional para las plantas.
EP2007368A2 (en) * 2006-04-04 2008-12-31 Hill's Pet Nutrition Inc. Compositions and methods for enhancing the antioxidant status of animals
MX2009007701A (es) * 2007-01-19 2009-07-29 Iams Company Composicion y metodo de ingrediente sensible estabilizado.
JP2008214338A (ja) * 2007-02-08 2008-09-18 Shiseido Co Ltd 高次脳機能低下改善剤および遅延記憶低下改善剤
AU2008231241B2 (en) * 2007-02-22 2011-11-10 Hill's Pet Nutrition, Inc. Compositions and methods for enhancing neurologic development
US20120189563A1 (en) * 2009-09-30 2012-07-26 Shiseido Company, Ltd. Oral composition for alleviating ultraviolet irradiation-induced damage
CA2785997A1 (en) * 2010-01-06 2011-07-14 Nestec S.A. Dietary regimens useful for mimicking caloric restriction
CN101828646B (zh) * 2010-05-25 2012-07-18 中国农业大学 一种抗热应激饲料添加剂及其应用
EP2651239A1 (en) * 2010-12-16 2013-10-23 Spécialités Pet Food Method for producing highly palatable dry cat food
US20140005268A1 (en) * 2011-01-19 2014-01-02 Eduardo Motta Alves Peixoto Pharmaceutical composition for treating oxidative stress-induced pathology and use thereof
CN102326675A (zh) * 2011-09-09 2012-01-25 南京农业大学 一种抗氧化饲料添加剂及其应用
CN102657297A (zh) * 2012-05-30 2012-09-12 扬州大学 一种调控高产奶牛围产期氧化应激的方法
JP2014018172A (ja) * 2012-07-20 2014-02-03 Kohjin Life Sciences Co Ltd 過酸化脂質生成を抑制するペットフード
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
JP6976035B2 (ja) * 2015-11-20 2021-12-01 ユニ・チャーム株式会社 ペットフードおよびその製造方法
GB201804698D0 (en) * 2018-03-23 2018-05-09 Mars Inc Reduced methionine diet for dogs
GB201908111D0 (en) * 2019-06-06 2019-07-24 Mars Inc Modulation of the oral microbiota
CN110537630A (zh) * 2019-09-09 2019-12-06 天津农学院 1，2二硫戊环-3-戊酸的应用、幼犬鲜粮和延长幼犬鲜粮贮藏期的方法
US11896581B2 (en) 2020-09-04 2024-02-13 Société des Produits Nestlé S.A. Compositions and methods for providing health benefits in an animal

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
GB1497211A (en) * 1974-04-04 1978-01-05 Sandoz Ltd Soft moist animal diet feed
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
US4267195A (en) * 1976-09-10 1981-05-12 University Of Texas Dog food flavors
US4267196A (en) 1977-09-02 1981-05-12 Johnston Ian F Food from non-edible fruit by-products and method for production
JPS56127054A (en) * 1980-02-28 1981-10-05 Uni Tekisasu Dog food flavor
JPS5865785A (ja) 1981-10-16 1983-04-19 Riyoushiyoku Kenkyukai 抗酸化剤の製法
GB8726662D0 (en) * 1987-11-13 1987-12-16 Shell Int Research Imidazole dioxolane & 1 3-dioxane derivatives
US4927850A (en) 1988-04-08 1990-05-22 Bayless Robert K Antioxidant compositions and methods for ameliorating inflammatory symptoms of respiratory disease
US5053429A (en) * 1988-04-08 1991-10-01 The Lithox Corporation, Inc. Treating inflammatory pain with methionine
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
JPH05320036A (ja) 1992-05-19 1993-12-03 Shiseido Co Ltd 一重項酸素除去組成物
AU7596994A (en) † 1993-11-01 1995-05-18 Free Radical Sciences, Inc. Methods and compositions for retarding the aging process
US5571523A (en) * 1995-03-09 1996-11-05 President And Fellows Of Harvard College Antioxidant-induced apoptosis in vascular smooth muscle cells
US6245364B1 (en) * 1996-02-29 2001-06-12 International Flora Technologies, Ltd. Weight reduction method for cats and other pets
ZA965149B (en) * 1996-06-18 1997-01-23 Henry John Davis Vitamin and nutrient supplement compositions
GB2315674B (en) * 1996-08-01 2000-06-21 Richard John Cleeve Mammalian foodstuff
CN1142940C (zh) 1996-10-04 2004-03-24 安姆根有限公司 含有mpl配体的药物组合物
US5883083A (en) * 1997-06-09 1999-03-16 Harlmen, Inc. Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
US6245379B1 (en) 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
CA2285490C (en) * 1999-10-07 2003-11-18 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US20030060503A1 (en) * 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
CA2399319A1 (en) 2000-01-25 2001-08-16 Nathan D. Hamilton Nutritional supplements for aged pets
WO2001060778A2 (en) 2000-02-16 2001-08-23 The Brigham And Women's Hospital, Inc. Aspirin-triggered lipid mediators
US6495170B1 (en) † 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20020115710A1 (en) * 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
US6277435B1 (en) 2001-02-26 2001-08-21 Martine Lacombe Kosher-meat based pet food products
DE20104950U1 (de) * 2001-03-22 2001-08-30 Neuendorf, Ernst-Günter, 31737 Rinteln Futtermittelmischung für Haustiere aus pflanzlichen Komponenten
US20030124230A1 (en) * 2001-06-01 2003-07-03 Jan Zielinski Methods and products for bad breath
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US6582752B2 (en) * 2001-11-02 2003-06-24 Nestec, Ltd Methods and compositions for a gender specific diet for puppies
GB0202258D0 (en) * 2002-01-31 2002-03-20 Dodson & Horrell Ltd Annimal feed supplement
CN1816284A (zh) 2003-07-03 2006-08-09 希尔氏宠物营养品公司 减少伴侣动物年龄相关性精神活动衰退的组合物和方法
DE602004029039D1 (de) 2003-07-07 2010-10-21 Hills Pet Nutrition Inc Zusammensetzungen für einen verbesserten oxidationsstatus bei katzen
US20050079247A1 (en) 2003-10-14 2005-04-14 Slilaty George E. Food composition and method of making same
EP2007368A2 (en) 2006-04-04 2008-12-31 Hill's Pet Nutrition Inc. Compositions and methods for enhancing the antioxidant status of animals
JP5320036B2 (ja) 2008-11-20 2013-10-23 住友電気工業株式会社 スプリッタモジュール

Also Published As

Publication number Publication date
EP1641352A1 (en) 2006-04-05
EP1641352B2 (en) 2019-06-19
RU2006103371A (ru) 2006-06-10
US8835497B2 (en) 2014-09-16
ZA200600175B (en) 2007-04-25
CA2529377A1 (en) 2005-01-27
MXPA05013251A (es) 2006-03-09
RU2358440C2 (ru) 2009-06-20
CA2529377C (en) 2012-06-19
DE602004029039D1 (de) 2010-10-21
JP6334086B2 (ja) 2018-05-30
BRPI0412332A (pt) 2006-09-05
US20140316005A1 (en) 2014-10-23
AU2004257683B2 (en) 2010-09-02
ES2349927T3 (es) 2011-01-13
US20050014698A1 (en) 2005-01-20
EP1641352B1 (en) 2010-09-08
ATE480152T1 (de) 2010-09-15
CN101052312A (zh) 2007-10-10
WO2005006878A1 (en) 2005-01-27
AU2004257683A1 (en) 2005-01-27
JP2017014227A (ja) 2017-01-19
JP2007525201A (ja) 2007-09-06
CN101052312B (zh) 2013-02-13
US20100234461A1 (en) 2010-09-16
JP6389214B2 (ja) 2018-09-12
JP2013082713A (ja) 2013-05-09

Similar Documents

Publication Publication Date Title
DK1641352T3 (da) Sammensætninger til forbedret oxidativ status hos katte
BR0209312A (pt) Composição alimentìcia de isolado de proteìna de canola
SI1587821T1 (sl) Sestavki in postopki za stabiliziranje transtiretina in zaviranje napaäśnega zvijanja transtiretina
EA200701528A1 (ru) Новые нутрицевтические композиции
WO2006069241A3 (en) Methods for promoting oral health in animals
ATE464041T1 (de) Zusammensetzung zur hautaufhellung
TNSN07222A1 (en) Nematicidal compositions
EP1845787A4 (en) FORMULATIONS FOR THE INJECTION OF CATECHOLIC BUTANAS, INCLUDING NDGA COMPOUNDS, TO ANIMALS
WO2007002837A3 (en) Methods and compositions for the prevention and treatement of inflammatory disease
BRPI0602150A (pt) composição antimicrobiana sinergìstica
ECSP066484A (es) Compuestos y metodos para el tratamiento de dislipidemia
ATE452646T1 (de) Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
DK1659880T3 (da) Sammensætning til dyreernæring
DE60316821D1 (de) Aminobenzothiazolverbindungen mit nos-hemmender wirkung
WO2006071952A3 (en) Compositions and methods for improving kidney function
DE50305507D1 (de) Zusammensetzungen zur herstellung von aminoplasterzeugnissen
HK1112592A1 (en) Composition for reducing the exudation of serum proteins
ATE519380T1 (de) Unterstützung der kognitiven funktion
DE602006015230D1 (de) Haarbehandlungszusammensetzungen
DE602006012682D1 (de) Naphthalinonderivat mit gerüchen vom pulvrigen ionon-typ
TW200637603A (en) Oral treatment compositions containing anti-adhesion agent, antibacterial agent and incompatible compound
ATE442055T1 (de) Fischfutter mit sojaprotein
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
TW200608900A (en) Feed complement for animals comprising an olfactory additive